<DOC>
	<DOCNO>NCT00914433</DOCNO>
	<brief_summary>This study look safety tolerability TPI 1100 healthy volunteer look pharmacodynamic ( PD ) effect mRNA expression PDE 4B/D &amp; 7A blood sputum .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacodynamics Pharmacokinetics Inhaled TPI 1100 Healthy Volunteers</brief_title>
	<detailed_description>Study initiate terminate start-up .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Healthy , male female volunteer age 18 55 year inclusive Screening/baseline FEV1 great 90 % predict , Body mass index ( BMI ) 19 28 inclusive , Clinical laboratory value and/or vital sign within normal reference range consider clinically significant Investigator Airways systemic condition might affect respiratory function , include limit clinically significant cardiac problem , Breastfeeding pregnancy , Positive test smoke tobacco , alcohol , hepatitis Bsurface antigen , hepatitis C antibody , HIV screening , History serious adverse reaction drug ,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>COPD</keyword>
</DOC>